Motif ID: Glis3
Z-value: 0.591

Transcription factors associated with Glis3:
Gene Symbol | Entrez ID | Gene Name |
---|---|---|
Glis3 | ENSMUSG00000052942.7 | Glis3 |
Glis3 | ENSMUSG00000091294.1 | Glis3 |
Activity-expression correlation:
Gene Symbol | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Glis3 | mm10_v2_chr19_-_28680077_28680122 | 0.01 | 9.8e-01 | Click! |
Top targets:
Showing 1 to 20 of 116 entries
Gene overrepresentation in biological_process category:
Showing 1 to 20 of 39 entries
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 6.4 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.3 | 2.4 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
0.1 | 0.9 | GO:0060746 | parental behavior(GO:0060746) |
0.1 | 0.7 | GO:0070814 | hydrogen sulfide biosynthetic process(GO:0070814) |
0.1 | 0.6 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.1 | 0.6 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.1 | 0.6 | GO:0019368 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.0 | 0.6 | GO:0060325 | face morphogenesis(GO:0060325) |
0.1 | 0.5 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.1 | 0.5 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.0 | 0.5 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.1 | 0.4 | GO:0070172 | oculomotor nerve development(GO:0021557) positive regulation of tooth mineralization(GO:0070172) |
0.1 | 0.4 | GO:0071649 | regulation of chemokine (C-C motif) ligand 5 production(GO:0071649) |
0.1 | 0.4 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.1 | 0.4 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.1 | 0.3 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.1 | 0.3 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
0.0 | 0.3 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.0 | 0.3 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.0 | 0.3 | GO:0060613 | fat pad development(GO:0060613) |
Gene overrepresentation in cellular_component category:
Showing 1 to 14 of 14 entries
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 2.4 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.0 | 0.7 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.0 | 0.7 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.1 | 0.5 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.0 | 0.5 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.0 | 0.4 | GO:0031011 | Ino80 complex(GO:0031011) |
0.0 | 0.4 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.1 | 0.3 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.0 | 0.2 | GO:0071556 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) integral component of lumenal side of endoplasmic reticulum membrane(GO:0071556) lumenal side of endoplasmic reticulum membrane(GO:0098553) |
0.0 | 0.2 | GO:0033503 | HULC complex(GO:0033503) |
0.0 | 0.2 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.0 | 0.2 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.0 | 0.1 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.0 | 0.1 | GO:0031084 | BLOC-2 complex(GO:0031084) |
Gene overrepresentation in molecular_function category:
Showing 1 to 20 of 27 entries
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 6.4 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.6 | 2.4 | GO:0005008 | hepatocyte growth factor-activated receptor activity(GO:0005008) |
0.0 | 0.9 | GO:0001103 | RNA polymerase II repressing transcription factor binding(GO:0001103) |
0.0 | 0.8 | GO:0019003 | GDP binding(GO:0019003) |
0.1 | 0.6 | GO:0008494 | translation activator activity(GO:0008494) |
0.1 | 0.6 | GO:0102338 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.0 | 0.6 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.1 | 0.5 | GO:0035240 | dopamine binding(GO:0035240) |
0.1 | 0.5 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.1 | 0.4 | GO:0050700 | CARD domain binding(GO:0050700) |
0.0 | 0.4 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.0 | 0.4 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.0 | 0.3 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.0 | 0.3 | GO:0045545 | syndecan binding(GO:0045545) |
0.0 | 0.3 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.0 | 0.3 | GO:0031386 | protein tag(GO:0031386) |
0.0 | 0.3 | GO:0035198 | miRNA binding(GO:0035198) |
0.0 | 0.3 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.1 | 0.2 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
0.1 | 0.2 | GO:0005534 | galactose binding(GO:0005534) |